Angus MacLeod, David Della Penta | GenomeWeb

Galapagos said this week that Angus MacLeod has joined the company's service division BioFocus as director of medicinal chemistry.

MacLeod previously worked at Merck Sharp & Dohme, most recently as senior director of medicinal chemistry, Galapagos said.


Fisher Scientific said this week that President and CEO David Della Penta will retire at the end of 2006.

He has been with Fisher since 1998. The company said additional announcements regarding his successor will be made later in the year.

 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.